Moreover, it has been proposed by researchers that statins modulate the inflamed tumor microenvironment (TME) and potentiate anti–PD-1 immunotherapy in NSCLC by transcriptionally repressing PD-L1 and promoting ferroptosis (29). Here, CD274 is linked to neoplasm.